Increased postimplantation loss and malformations among the F2 progeny of male rats chronically treated with cyclophosphamide
- 2 June 1992
- journal article
- Published by Wiley in Teratology
- Vol. 45 (6) , 671-678
- https://doi.org/10.1002/tera.1420450612
Abstract
Cyclophosphamide, administered to the male rat, produces increased pre‐ and postimplantation loss in the progeny as well as an increase in the numbers of malformed and growth retarded fetuses. The purpose of this study was to determine whether the adverse effects of chronic paternal cyclophosphamide exposure are transmissible to the next generation, the F2 progeny. Adult male rats were treated by gavage daily with saline or with cyclophosphamide (3.4 or 5.1 mg/kg) for 4 or 18 weeks and mated. The male and female offspring in each treatment group (F1 generation) were randomly mated. The resulting pregnant females were killed on day 20 of gestation to evaluate progeny outcome in the F2 generation. There was a significant increase in postimplantation loss among the offspring of the group whose fathers had been treated with cyclophosphamide at a dose of 5.1 mg/kg/day. Exposure to a dose of 5.1 mg/kg/day of cyclophosphamide also resulted in an F2 generation with a significantly decreased mean fetal weight per litter and a significant increase in the number of malformed fetuses. The malformations observed among the F2 progeny included open eyes, omphalocele, generalized edema, syndactyly, gigantism, and dwarfism. Thus, exposure of the father to cyclophosphamide does result in a specific and heritable alteration in the fertility of the surviving “apparently normal” F1 progeny. Interestingly, the adverse consequences of exposure of male rats to cyclophosphamide are similar in the F2 generation to those previously reported for the F1 progeny.Keywords
This publication has 25 references indexed in Scilit:
- Cyclosphamide in the F0 male rat: physical and behavioral changes in three successive adult generationsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Malformed foetuses and karyotype abnormalities in the offspring of cyclophosphamide and allyl alcohol-treated male ratsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Reversibility of the effects of chronic paternal exposure to cyclophosphamide on pregnancy outcome in ratsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Genotoxic potency in mouse spermatogonial stem cells of triethylenemelamine, mitomycin C, ethylnitrosourea, procarbazine, and propyl methanesulfonate as measured by F1 congenital defectsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Tumours and malformations in the adult offspring of cyclophosphamide-treated and control male rats — Perliminary communicationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Antimitotic Drugs in the Male Rat Behavioral Abnormalities in the Second GenerationJournal of Andrology, 1988
- Induction of specific-locus and dominant-lethal mutations by cyclophosphamide and combined cyclophosphamide-radiation treatment in male miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Induction of congenital malformation in mice by parental irradiation: transmission to later generationsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1988
- Difference between two hybrid stocks of mice in the incidence of congenital abnormalities following X-ray exposure of stem-cell spermatogoniaMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1986
- Induction of dominant lethal mutations by alkylating agents in male miceMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1968